Bio-Thera Solutions, Ltd. (SHA:688177)
26.32
+0.02 (0.08%)
At close: May 30, 2025, 2:57 PM CST
Bio-Thera Solutions Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Operating Revenue | 787.98 | 743.01 | 704.41 | 455.13 | 836.58 | 182.86 | Upgrade
|
Other Revenue | 0.15 | 0.15 | 0.38 | 0 | - | - | Upgrade
|
Revenue | 788.13 | 743.17 | 704.79 | 455.13 | 836.58 | 182.86 | Upgrade
|
Revenue Growth (YoY) | 10.78% | 5.44% | 54.85% | -45.60% | 357.49% | 26023.37% | Upgrade
|
Cost of Revenue | 228.6 | 229.7 | 194.67 | 191.09 | 35.9 | 19.92 | Upgrade
|
Gross Profit | 559.53 | 513.46 | 510.13 | 264.04 | 800.68 | 162.95 | Upgrade
|
Selling, General & Admin | 282.8 | 269.62 | 201.3 | 174.24 | 215.45 | 163.47 | Upgrade
|
Research & Development | 786.23 | 777.63 | 768.64 | 616.39 | 543.42 | 562.65 | Upgrade
|
Other Operating Expenses | 7.85 | 5.02 | 4.91 | 3.34 | 2.17 | 1.59 | Upgrade
|
Operating Expenses | 1,077 | 1,053 | 975.04 | 793.26 | 761.93 | 727.82 | Upgrade
|
Operating Income | -517.62 | -539.04 | -464.91 | -529.22 | 38.75 | -564.87 | Upgrade
|
Interest Expense | -22.08 | -20.55 | -10.38 | -0.06 | -0.78 | -3.7 | Upgrade
|
Interest & Investment Income | 5.91 | 4.98 | 8.3 | 15.53 | 21.68 | 18.3 | Upgrade
|
Currency Exchange Gain (Loss) | 0.68 | 0.68 | -0.15 | 1.86 | 1.47 | 0.35 | Upgrade
|
Other Non Operating Income (Expenses) | -0.23 | -0.25 | -0.33 | -0.26 | -0.39 | -0.47 | Upgrade
|
EBT Excluding Unusual Items | -533.35 | -554.18 | -467.47 | -512.15 | 60.74 | -550.39 | Upgrade
|
Gain (Loss) on Sale of Investments | 2.16 | 3.45 | 6.97 | 14.53 | 11.9 | 18.81 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.5 | -0.51 | 0.03 | -0.07 | -0.02 | -0.17 | Upgrade
|
Asset Writedown | 0.03 | - | - | - | - | -0.13 | Upgrade
|
Other Unusual Items | 46.97 | 40.94 | 66.05 | 17.29 | 18.42 | 18.67 | Upgrade
|
Pretax Income | -484.68 | -510.3 | -394.42 | -480.4 | 91.04 | -513.23 | Upgrade
|
Income Tax Expense | - | - | 0.11 | 0 | 9.11 | - | Upgrade
|
Net Income | -484.68 | -510.3 | -394.53 | -480.4 | 81.94 | -513.23 | Upgrade
|
Net Income to Common | -484.68 | -510.3 | -394.53 | -480.4 | 81.94 | -513.23 | Upgrade
|
Shares Outstanding (Basic) | 414 | 415 | 415 | 414 | 410 | 404 | Upgrade
|
Shares Outstanding (Diluted) | 414 | 415 | 415 | 414 | 410 | 404 | Upgrade
|
Shares Change (YoY) | 0.19% | -0.10% | 0.28% | 1.09% | 1.38% | 16.97% | Upgrade
|
EPS (Basic) | -1.17 | -1.23 | -0.95 | -1.16 | 0.20 | -1.27 | Upgrade
|
EPS (Diluted) | -1.17 | -1.23 | -0.95 | -1.16 | 0.20 | -1.27 | Upgrade
|
Free Cash Flow | -26.33 | -182.5 | -723.01 | -671.64 | 158.38 | -611.3 | Upgrade
|
Free Cash Flow Per Share | -0.06 | -0.44 | -1.74 | -1.62 | 0.39 | -1.51 | Upgrade
|
Gross Margin | 70.99% | 69.09% | 72.38% | 58.01% | 95.71% | 89.11% | Upgrade
|
Operating Margin | -65.68% | -72.53% | -65.96% | -116.28% | 4.63% | -308.90% | Upgrade
|
Profit Margin | -61.50% | -68.67% | -55.98% | -105.55% | 9.79% | -280.66% | Upgrade
|
Free Cash Flow Margin | -3.34% | -24.56% | -102.58% | -147.57% | 18.93% | -334.30% | Upgrade
|
EBITDA | -431.98 | -454.21 | -383.34 | -448.35 | 108.87 | -505.9 | Upgrade
|
EBITDA Margin | -54.81% | -61.12% | -54.39% | -98.51% | 13.01% | -276.65% | Upgrade
|
D&A For EBITDA | 85.65 | 84.83 | 81.57 | 80.88 | 70.12 | 58.98 | Upgrade
|
EBIT | -517.62 | -539.04 | -464.91 | -529.22 | 38.75 | -564.87 | Upgrade
|
EBIT Margin | -65.68% | -72.53% | -65.96% | -116.28% | 4.63% | - | Upgrade
|
Effective Tax Rate | - | - | - | - | 10.00% | - | Upgrade
|
Revenue as Reported | 788.13 | 743.17 | 704.79 | 455.13 | 836.58 | 184.99 | Upgrade
|
Advertising Expenses | - | - | - | - | - | 7.77 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.